Literature DB >> 29046994

Peripheral markers of autophagy in polyglutamine diseases.

Giorgia Puorro1, Angela Marsili1, Francesca Sapone1, Chiara Pane1, Anna De Rosa1, Silvio Peluso1, Giuseppe De Michele1, Alessandro Filla1, Francesco Saccà2.   

Abstract

Polyglutamine disorders are neurodegenerative diseases that share a CAG repeat expansion in the coding region, resulting in aggregated proteins that can be only degraded through aggrephagy. We measured the expression of autophagy genes in peripheral blood mononuclear cells of 20 patients with Huntington's disease (HD), 20 with spinocerebellar ataxia type 2 (SCA2), and 20 healthy individuals. HD patients showed increased expression of MAP1LC3B (+ 43%; p = 0.048), SQSTM1 (+ 49%; p = 0.002), and WDFY3 (+ 89%; p < 0.001). SCA2 patients had increased expression of WDFY3 (+ 69%; p < 0.001). We show that peripheral markers of autophagy are elevated in polyQ diseases, and this is particularly evident in HD.

Entities:  

Keywords:  Autophagy; Huntington’s disease; MAP1LC3B; SCA2; SQSTM1; Spinocerebellar ataxia type 2; WDFY3

Mesh:

Substances:

Year:  2017        PMID: 29046994     DOI: 10.1007/s10072-017-3156-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  12 in total

1.  SCA Functional Index: a useful compound performance measure for spinocerebellar ataxia.

Authors:  T Schmitz-Hübsch; P Giunti; D A Stephenson; C Globas; L Baliko; F Saccà; C Mariotti; M Rakowicz; S Szymanski; J Infante; B P C van de Warrenburg; D Timmann; R Fancellu; R Rola; C Depondt; L Schöls; E Zdzienicka; J-S Kang; S Döhlinger; B Kremer; B Melegh; A Filla; T Klockgether
Journal:  Neurology       Date:  2008-08-12       Impact factor: 9.910

Review 2.  Repeat expansion disease: progress and puzzles in disease pathogenesis.

Authors:  Albert R La Spada; J Paul Taylor
Journal:  Nat Rev Genet       Date:  2010-04       Impact factor: 53.242

Review 3.  p62/SQSTM1 functions as a signaling hub and an autophagy adaptor.

Authors:  Yoshinori Katsuragi; Yoshinobu Ichimura; Masaaki Komatsu
Journal:  FEBS J       Date:  2015-10-16       Impact factor: 5.542

4.  Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human.

Authors:  D P Huynh; K Figueroa; N Hoang; S M Pulst
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

5.  HTT/Huntingtin in selective autophagy and Huntington disease: A foe or a friend within?

Authors:  Yan-Ning Rui; Zhen Xu; Bindi Patel; Ana Maria Cuervo; Sheng Zhang
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

6.  Expansion of the polyQ repeat in ataxin-2 alters its Golgi localization, disrupts the Golgi complex and causes cell death.

Authors:  Duong P Huynh; Hai-Tao Yang; Hema Vakharia; Dung Nguyen; Stefan M Pulst
Journal:  Hum Mol Genet       Date:  2003-07-01       Impact factor: 6.150

7.  Clinical use of frataxin measurement in a patient with a novel deletion in the FXN gene.

Authors:  Francesco Saccà; Angela Marsili; Giorgia Puorro; Antonella Antenora; Chiara Pane; Alessandra Tessa; Pasquale Scoppettuolo; Claudia Nesti; Vincenzo Brescia Morra; Giuseppe De Michele; Filippo M Santorelli; Alessandro Filla
Journal:  J Neurol       Date:  2012-11-30       Impact factor: 4.849

8.  Huntingtin is required for ER-to-Golgi transport and for secretory vesicle fusion at the plasma membrane.

Authors:  Hemma Brandstaetter; Antonina J Kruppa; Folma Buss
Journal:  Dis Model Mech       Date:  2014-10-31       Impact factor: 5.758

Review 9.  Role of the mammalian ATG8/LC3 family in autophagy: differential and compensatory roles in the spatiotemporal regulation of autophagy.

Authors:  You-Kyung Lee; Jin-A Lee
Journal:  BMB Rep       Date:  2016-08       Impact factor: 4.778

10.  A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin.

Authors:  Sovan Sarkar; Gauri Krishna; Sara Imarisio; Shinji Saiki; Cahir J O'Kane; David C Rubinsztein
Journal:  Hum Mol Genet       Date:  2007-10-06       Impact factor: 6.150

View more
  7 in total

1.  Huntington Disease Gene Expression Signatures in Blood Compared to Brain of YAC128 Mice as Candidates for Monitoring of Pathology.

Authors:  Elsa C Kuijper; Lodewijk J A Toonen; Maurice Overzier; Roula Tsonaka; Kristina Hettne; Marco Roos; Willeke M C van Roon-Mom; Eleni Mina
Journal:  Mol Neurobiol       Date:  2022-01-29       Impact factor: 5.590

2.  Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice.

Authors:  Hayley S McLoughlin; Lauren R Moore; Ravi Chopra; Robert Komlo; Megan McKenzie; Kate G Blumenstein; Hien Zhao; Holly B Kordasiewicz; Vikram G Shakkottai; Henry L Paulson
Journal:  Ann Neurol       Date:  2018-08-06       Impact factor: 10.422

3.  Autophagy in Spinocerebellar ataxia type 2, a dysregulated pathway, and a target for therapy.

Authors:  Adriana Marcelo; Inês T Afonso; Ricardo Afonso-Reis; David V C Brito; Rafael G Costa; Ana Rosa; João Alves-Cruzeiro; Benedita Ferreira; Carina Henriques; Rui J Nobre; Carlos A Matos; Luís Pereira de Almeida; Clévio Nóbrega
Journal:  Cell Death Dis       Date:  2021-11-29       Impact factor: 8.469

4.  DYNLT1 gene expression is downregulated in whole blood of patients at different Huntington's disease stages.

Authors:  S M Rosseto; T A Alarcon; D M C Rocha; F M Ribeiro; S S G Ferguson; C Martins-Silva; M R Muniz; P F Costa; D A Guimarães; Rita G W Pires
Journal:  Neurol Sci       Date:  2020-09-29       Impact factor: 3.307

5.  Involvement of Beclin‑1 in axonal protection by short‑term hyperglycemia against TNF‑induced optic nerve damage.

Authors:  Kana Sase; Yasushi Kitaoka; Chihiro Tsukahara; Hitoshi Takagi
Journal:  Mol Med Rep       Date:  2018-10-22       Impact factor: 2.952

6.  Akebia Saponin D prevents axonal loss against TNF-induced optic nerve damage with autophagy modulation.

Authors:  Kana Sase; Chihiro Tsukahara; Naoki Fujita; Ibuki Arizono; Hitoshi Takagi; Yasushi Kitaoka
Journal:  Mol Biol Rep       Date:  2020-11-28       Impact factor: 2.316

Review 7.  The emerging roles of long non-coding RNAs in polyglutamine diseases.

Authors:  Xiaoyu Dong; Shuyan Cong
Journal:  J Cell Mol Med       Date:  2021-07-28       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.